- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Bortezomib – March 2016
Bortezomib: 3 mg injection, 3 mg vial, Velcade®
Last updated
1 July 2016